The US Food and Drug Administration is planning to hold a public hearing on issues that would help advance the development of medical products, including medical devices, drugs and biologics, used in the prevention, diagnosis and treatment of neglected tropical diseases1...
Scrip Regulatory Affairs
US FDA aims to boost drug development for neglected tropical diseases
22 July 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- US FDA gets tough on financial disclosures by clinical investigators
- US FDA gets tough on financial disclosures by clinical investigators
- User fees for biosimilars "comparable" to innovator fees under US FDA proposals
- Industry and European Commission tackle barriers to biosimilars market penetration
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
